Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous T-cell lymphomas

E Samuelson1

  • 1Robert H. Lurie Cancer Center, Northwestern University, Chicago, IL, USA.

Seminars in Oncology Nursing
|December 5, 1998
PubMed
Summary

Cutaneous T-cell lymphoma (CTCL), including mycosis fungoides and Sezary syndrome, is increasingly diagnosed. Advances in immunology and cellular biology are evolving treatment strategies for this rare but devastating malignancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromosome ideograms of the laboratory rat (Rattus norvegicus) based on high-resolution banding, and anchoring of the cytogenetic map to the DNA sequence by FISH in sample chromosomes.

Cytogenetic and genome research·2006
Same author

Analysis of chromosomal aberrations involving chromosome 1q31-->q53 in a DMBA-induced rat fibrosarcoma cell line: amplification and overexpression of Jak2.

Cytogenetics and cell genetics·2002
Same author

Interleukin-1 alpha increases the preferential cytotoxicity of an interleukin-2-diphtheria toxin fusion protein against neoplastic lymphocytes from patients with the Sezary syndrome compared to normal lymphocytes.

Journal of clinical immunology·1998
Same author

2-Chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disorders.

Leukemia & lymphoma·1997
Same author

Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome.

Blood·1997
Same author

Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma.

Blood·1996

Area of Science:

  • Oncology
  • Dermatology
  • Immunology

Background:

  • Cutaneous T-cell lymphoma (CTCL) encompasses rare malignancies like mycosis fungoides and Sezary syndrome.
  • These conditions present unique challenges in diagnosis and management.

Purpose of the Study:

  • To provide a comprehensive overview of the pathology, clinical presentation, and treatment of CTCL.
  • To outline current nursing management strategies for patients with mycosis fungoides and Sezary syndrome.

Main Methods:

  • Literature review encompassing book chapters, review articles, and research studies.
  • Inclusion of proceedings from professional meetings to capture current advancements.

Main Results:

  • Epidemiologic data indicate a rising incidence of mycosis fungoides and Sezary syndrome.
  • Ongoing research in cellular biology and immunology continuously refines diagnostic and therapeutic approaches.

Conclusions:

  • Oncology nurses require up-to-date knowledge to effectively manage patients with CTCL.
  • Understanding the evolving landscape of CTCL is crucial for providing optimal patient care for this chronic condition.

Related Experiment Videos